Bridgefront Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Bridgefront Capital's OGN Position: Q2 2026 in Review
Bridgefront Capital opened a new position in Organon & Co (OGN) in Q2 2026: 12,067 shares worth $163K. The stake represents 0.04% of the portfolio and ranks #469 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in OGN as recently as Q4 2025.
Bridgefront Capital first reported a position in OGN in Q1 2023 and has held it in 8 quarters since. The position peaked at $654K in Q2 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Bridgefront Capital held 12,067 shares of Organon & Co worth $163K as of Q2 2026.
- Organon & Co was a new Bridgefront Capital position in Q2 2026.
- Organon & Co made up 0.04% of Bridgefront Capital's portfolio in Q2 2026, its #469 holding.
- Bridgefront Capital first reported a position in Organon & Co in Q1 2023 and has held it in 8 quarters since.
- Bridgefront Capital's Organon & Co position peaked at $654K in Q2 2025.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.